as my colleague Senator Menendez indicated, the intent of the language in the FDA Reauthorization Act is this: so long as the submission process for a given product is begun by the sponsor on or before September 30, 2017, the product would qualify for a priority review voucher under the neglected tropical disease priority review voucher program.
Share
More from Johnny Isakson
I commend my colleague from New York for his tireless work to ensure that the brave men and women who selflessly responded to the terrorist attacks on September 11, 2001, receive the compensation and care they deserve. Out of respect for…
today I am proud to recognize in the Record the U.S. Department of Veterans Affairs, VA, Principal Deputy Assistant Secretary for the Office of Congressional and Legislative Affairs, OCLA, Christopher E. O'Connor, in honor of his upcoming…
I thank the Senator from Pennsylvania. If you want to go home on time, if you want to take something home to give to the American people that they want and they need, then you will vote with me and the other Members who have spoken on the…
the Committee on Veterans' Affairs has adopted rules governing its procedures for the 116th Congress. Pursuant to rule XXVI, paragraph 2, of the Standing Rules of the Senate, on behalf of myself and Senator Tester, I ask unanimous consent…
Other voices in this conversation
